异常 发表于 2025-3-23 12:24:59

Submitted on: 11 July 2004.
Revised on: 23 October 2004.
Accepted on: 03 December 2004.

___________________CLINICAL DRUG INVESTIGATION---ADIS INT LTD

Ataxia 发表于 2025-3-23 15:01:30

http://reply.papertrans.cn/1/57/5609/5609-12.png

sleep-spindles 发表于 2025-3-23 21:38:20

http://reply.papertrans.cn/1/57/5609/5609-13.png

artless 发表于 2025-3-24 01:02:52

Submitted on: 23 September 2019.
Revised on: 28 November 2019.
Accepted on: 12 December 2019.

___________________CLINICAL DRUG INVESTIGATION---ADIS INT LTD

导师 发表于 2025-3-24 04:17:32

http://reply.papertrans.cn/1/57/5609/5609-15.png

艰苦地移动 发表于 2025-3-24 08:13:38

http://reply.papertrans.cn/1/57/5609/5609-16.png

inconceivable 发表于 2025-3-24 13:33:40

http://reply.papertrans.cn/1/57/5609/5609-17.png

受伤 发表于 2025-3-24 17:22:25

http://reply.papertrans.cn/1/57/5609/5609-18.png

收藏品 发表于 2025-3-24 20:15:54

http://reply.papertrans.cn/1/57/5609/5609-19.png

吗啡 发表于 2025-3-24 23:24:54

Submitted on: 12 April 2005.
Revised on: 31 July 2005.
Accepted on: 31 August 2005.

___________________CLINICAL DRUG INVESTIGATION---ADIS INT LTD
页: 1 [2] 3 4
查看完整版本: SCIE期刊CLINICAL DRUG INVESTIGATION 2024/2025影响因子:2.922 (CLIN DRUG INVEST) (1173-2563). (PHARMACOLOGY & PHARMACY)(药理学与药学)